Free Trial

Bright Minds Biosciences (DRUG) Institutional Ownership

Bright Minds Biosciences logo
$77.64 -6.94 (-8.21%)
Closing price 04:00 PM Eastern
Extended Trading
$77.66 +0.02 (+0.03%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)

Current
Institutional Ownership
Percentage
40.52%
Number of
Institutional Buyers
(last 12 months)
45
Total
Institutional Inflows
(last 12 months)
$133.93M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$59.78M
Get DRUG Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DRUG Institutional Buying and Selling by Quarter

Bright Minds Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.11,188$816K0.0%N/A0.115%
5/14/2026 Walleye Capital LLC53,706$3.92M0.0%+108.0%0.552%
5/5/2026 Bank of New York Mellon Corp13,253$967K0.0%+32.7%0.136%
4/28/2026 AdvisorShares Investments LLC12,613$920K0.2%+26.8%0.130%
4/25/2026 Strs Ohio2,700$197K0.0%+200.0%0.028%
2/23/2026Virtu Financial LLC2,897$226K0.0%N/A0.030%
2/19/2026 Invesco Ltd.4,198$328K0.0%N/A0.043%
2/18/2026Ikarian Capital LLC159,421$12.44M1.0%+933.1%1.638%
2/18/2026Wellington Management Group LLP13,688$1.07M0.0%N/A0.141%
2/18/2026Superstring Capital Management LP47,278$3.69M2.0%-12.4%0.486%
2/18/2026Millennium Management LLC194,437$15.17M0.0%+153.6%1.998%
2/18/2026Janus Henderson Group PLC1,155,995$90.83M0.0%+0.9%11.881%
2/18/2026Commodore Capital LP18,851$1.47M0.1%-96.2%0.194%
2/18/2026Artia Global Partners LP33,407$2.61M0.4%N/A0.343%
2/18/2026Balyasny Asset Management L.P.225,412$17.59M0.0%+20.6%2.317%
2/18/2026Boothbay Fund Management LLC47,490$3.71M0.1%+68.9%0.488%
2/17/2026ADAR1 Capital Management LLC3,500$273K0.0%N/A0.036%
2/17/2026Schonfeld Strategic Advisors LLC30,211$2.36M0.0%-54.6%0.310%
2/17/2026Braidwell LP324,358$25.31M0.8%+6.8%3.333%
2/17/2026MPM Bioimpact LLC230,147$17.96M2.1%N/A2.365%
2/17/2026Price T Rowe Associates Inc. MD2,830$221K0.0%N/A0.029%
2/17/2026Royal Bank of Canada527$40K0.0%+240.0%0.005%
2/16/2026Eventide Asset Management LLC103,013$8.04M0.1%N/A1.059%
2/16/2026Barclays PLC9,660$754K0.0%+46.8%0.099%
2/13/2026Marshall Wace LLP4,600$359K0.0%N/A0.047%
2/13/2026 Walleye Capital LLC25,826$2.02M0.0%-64.5%0.265%
2/13/2026Charles Schwab Investment Management Inc.12,465$973K0.0%+7.4%0.128%
2/13/2026State Street Corp77,278$6.03M0.0%+13.0%0.794%
2/13/2026 Wells Fargo & Company MN5,523$431K0.0%+95.4%0.057%
2/13/2026Platinum Investment Management Ltd.21,730$1.70M0.4%-23.2%0.223%
2/12/2026 Jane Street Group LLC9,018$704K0.0%-43.3%0.093%
2/12/2026 Nuveen LLC5,987$467K0.0%-52.1%0.062%
2/11/2026 Deutsche Bank AG4,259$332K0.0%+588.0%0.044%
2/10/2026Goldman Sachs Group Inc.48,547$3.79M0.0%N/A0.499%
2/10/2026 AdvisorShares Investments LLC9,944$776K0.1%-27.5%0.102%
2/10/2026 Seven Grand Managers LLC50,000$3.90M0.3%N/A0.514%
2/9/2026Geode Capital Management LLC63,546$4.96M0.0%+9.8%0.653%
1/1/2026JPMorgan Chase & Co.5,265$319K0.0%+142.3%0.068%
11/17/2025Vivo Capital LLC501,617$30.43M2.4%+99.4%7.121%
11/17/2025Millennium Management LLC76,681$4.65M0.0%-31.1%1.089%
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,048$124K0.0%-18.5%0.029%
11/17/2025Citadel Advisors LLC6,476$393K0.0%N/A0.092%
11/17/2025Bank of America Corp DE7,037$427K0.0%+48.6%0.100%
11/17/2025Boothbay Fund Management LLC28,119$1.71M0.0%+46.7%0.399%
11/17/2025Braidwell LP303,685$18.42M0.5%N/A4.311%
11/14/2025Schonfeld Strategic Advisors LLC66,606$4.04M0.0%-3.5%0.946%
11/14/2025Acuta Capital Partners LLC84,875$5.15M5.3%+75.1%1.205%
11/14/2025Balyasny Asset Management L.P.186,922$11.34M0.0%N/A2.654%
11/14/2025Two Sigma Investments LP10,711$650K0.0%N/A0.152%
11/13/2025 BNP Paribas Financial Markets4,796$291K0.0%+949.5%0.068%
11/13/2025Gordian Capital Singapore Pte Ltd1,200$73K0.1%N/A0.017%
11/13/2025 Russell Investments Group Ltd.951$58K0.0%N/A0.014%
11/7/2025Vanguard Group Inc.45,103$2.74M0.0%+41.0%0.641%
11/7/2025JPMorgan Chase & Co.5,265$319K0.0%+142.3%0.075%
11/5/2025 AdvisorShares Investments LLC13,709$832K0.1%-5.3%0.195%
11/3/2025 New York State Common Retirement Fund2,600$158K0.0%-36.6%0.037%
8/15/2025Perceptive Advisors LLC420,690$10.98M1.0%-5.4%5.976%
8/15/2025Bank of America Corp DE4,734$124K0.0%-12.6%0.067%
8/14/2025Acuta Capital Partners LLC48,474$1.27M1.8%-18.9%0.688%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,513$66K0.0%N/A0.036%
8/13/2025 Walleye Capital LLC53,430$1.40M0.0%-37.2%0.759%
8/13/2025Sio Capital Management LLC512,338$13.38M5.1%+0.9%7.278%
8/13/2025 New York State Common Retirement Fund4,100$107K0.0%N/A0.058%
8/12/2025JPMorgan Chase & Co.2,173$57K0.0%+624.3%0.031%
8/8/2025 Police & Firemen s Retirement System of New Jersey1,079$28K0.0%N/A0.015%
8/8/2025Geode Capital Management LLC57,521$1.50M0.0%N/A0.817%
8/4/2025 AdvisorShares Investments LLC14,481$378K0.1%+28.4%0.206%
6/27/2025Goldman Sachs Group Inc.22,222$802K0.0%N/A0.316%
5/16/2025Goldman Sachs Group Inc.22,222$802K0.0%N/A0.315%
5/16/2025Millennium Management LLC192,557$6.95M0.0%+376.9%2.734%
5/16/2025Adage Capital Partners GP L.L.C.200,000$7.21M0.0%+50.9%2.839%
5/15/2025RA Capital Management L.P.206,427$7.45M0.1%-55.2%2.931%
5/15/2025OMERS ADMINISTRATION Corp14,000$505K0.0%N/A0.199%
5/14/2025Walleye Capital LLC85,022$3.07M0.0%-17.6%1.207%
2/17/2025Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049%
2/17/2025Millennium Management LLC40,379$1.45M0.0%N/A0.911%
2/17/2025Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485%
2/17/2025Bank of America Corp DE4,793$173K0.0%N/A0.108%
2/17/2025Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560%
2/14/2025RA Capital Management L.P.460,829$16.60M0.2%N/A10.402%
2/14/2025Jane Street Group LLC6,600$238K0.0%N/A0.149%
2/14/2025Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576%
2/14/2025AdvisorShares Investments LLC3,075$111K0.0%-98.3%0.069%
2/14/2025Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006%
2/14/2025Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991%
2/14/2025Vivo Capital LLC251,572$9.06M1.0%N/A5.679%
2/13/2025Walleye Capital LLC103,192$3.72M0.0%N/A2.327%
2/13/2025Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369%
2/13/2025Atika Capital Management LLC15,000$540K0.1%N/A0.339%
2/14/2024AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246%
Millionaire warns: Move your money before May 15 (Ad)

Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2025 - says Trump's installation of a new Federal Reserve chair is triggering the most significant shift in U.S. markets in nearly 20 years. When the Fed cut rates in 2020, his readers had a chance at 62% gains. A 2022 rate-hike signal produced 117% in under a month. Now Benedict has identified the single ticker he believes will be at the center of the coming money flows - and he's revealing it free before May 15.tc pixel

Click here to see the one ticker Larry Benedict is recommending now
11/6/2023AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452%
8/9/2023AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640%
5/9/2023AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553%
8/8/2022AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439%
5/9/2022AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745%


DRUG Institutional Ownership - Frequently Asked Questions

During the previous two years, 56 institutional investors and hedge funds held shares of Bright Minds Biosciences. The most heavily invested institutionals were Janus Henderson Group PLC ($90.83M), Vivo Capital LLC ($30.43M), Braidwell LP ($25.31M), MPM Bioimpact LLC ($17.96M), Balyasny Asset Management L.P. ($17.59M), Millennium Management LLC ($15.17M), and Sio Capital Management LLC ($13.38M).Learn more on Bright Minds Biosciences' institutional investors.

40.52% of Bright Minds Biosciences' stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings.

Of the 51 institutional investors that purchased Bright Minds Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($519.11K), Vivo Capital LLC ($501.62K), RA Capital Management L.P. ($460.83K), Braidwell LP ($324.36K), Millennium Management LLC ($310.31K), MPM Bioimpact LLC ($230.15K), and Balyasny Asset Management L.P. ($225.41K).

Institutional investors have bought a total of 2,103,905 shares in the last 24 months. This purchase volume represents approximately $133.93M in transactions.

Of the 15 institutional investors that sold Bright Minds Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commodore Capital LP ($481.15K), RA Capital Management L.P. ($254.40K), Walleye Capital LLC ($78.52K), Schonfeld Strategic Advisors LLC ($38.79K), Millennium Management LLC ($34.69K), Perceptive Advisors LLC ($23.96K), and Acuta Capital Partners LLC ($11.27K).

Institutional investors have sold a total of 956,606 shares in the last 24 months. This volume of shares sold represents approximately $59.78M in transactions.



This page (NASDAQ:DRUG) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners